Kidney Stem Cell Clinical Trials

You may be eligible if.

Kidney stem cell clinical trials.

The harvard stem cell institute hsci kidney group has short medium and long term strategies to develop new therapies for diabetes related kidney damage diabetic nephropathy. This phase iii trial compares nephrectomy surgery to remove a kidney or part of a kidney with nivolumab to the usual approach of nephrectomy followed by standard post operative follow up and monitoring in treating patients with kidney cancer that is limited to a certain part of the body localized. Clinical trial of mesenchymal stem cells in the treatment of severe acute kidney injury wed 12 11 2019 12 00 conditions. There are currently no fda approved treatments for kidney disease that use stem cells but researchers are conducting clinical trials to test whether stem cell based therapies for kidney diseases are safe and effective in humans.

The website clinicaltrials gov has the most up to date information about the status of these trials. Explore all clinical trials at mayo clinic. Scientists are working on a promising approach to treat chronic kidney disease and kidney failure by harnessing the unique properties of human amniotic fluid derived stem cells the mixture of stem cells that can be. This multi pronged approach aims to capitalize on promising translational achievements in the near future while pursing potential drugs and the ultimate goal of.

You have been diagnosed with kidney cancer type clear cell. Find clinical trials to treat kidney cancer. Harvard university dedicates program specifically to kidney stem cell research for ckd and dialysis patients. You will stay at the clinical center nih s research hospital for at least 2 weeks after the re infusion of the boostered t cells.

Clinical trials are ongoing however with the goal of testing whether such therapies are effective and safe in humans. Regenerative cell based therapy applying mscs holds promise to delay the progression of kidney disease in individuals with diabetes mellitus. Find open clinical trials related to regenerative medicine therapy. Diabetic kidney disease also known as diabetic nephropathy is the most common cause of chronic kidney disease and end stage kidney failure requiring dialysis or kidney transplantation.

New therapies are being developed by the harvard stem cell institute to repair kidney damage and reduce the need for transplantation. Hickson is part of the research team looking at using stem cells to help regenerate failing kidneys. You can browse trials categorized by disease or condition or by procedure or can use specific search terms and filter results by location study status gender study phase and more. Learn about volunteering in a clinical trial.

Our goal is to take a look at how we can repair the diabetic kidney in terms of delaying the rate of progression of kidney failure says latonya hickson m d a mayo clinic nephrologist. Currently there are no stem cell treatments for kidney disease that are approved by the fda.